Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Development of Immunocompetence

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

Transcytosis of IgG

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Gut dysbiosis in cutaneous T-cell lymphoma is characterized by shifts in relative abundances of specific bacterial taxa and decreased diversity in more advanced disease.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022

Same author

Withholding or withdrawing life-sustaining treatment in extremely low gestational age neonates.

Archives of disease in childhood. Fetal and neonatal edition·2020

Same author

Clostridium difficile cure with fecal microbiota transplantation in a child with Pompe disease: a case report.

Journal of medical case reports·2018

Same author

Adjuvant pretreatment with alum protects neonatal mice in sepsis through myeloid cell activation.

Clinical and experimental immunology·2017

Same author

Barriers to enrollment in a randomized controlled trial of hydrocortisone for cardiovascular insufficiency in term and late preterm newborn infants.

Journal of perinatology : official journal of the California Perinatal Association·2017

Same author

A case of infant delirium in the neonatal intensive care unit.

Journal of neonatal-perinatal medicine·2017

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

Intravenous Injections in Neonatal Mice

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

Does IVIg administration yield improved immune function in very premature neonates?

J L Wynn¹, P C Seed, C M Cotten

¹Division of Neonatology, Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA. james.wynn@duke.edu

Journal of Perinatology : Official Journal of the California Perinatal Association

|January 8, 2010

Summary

Intravenous immunoglobulin (IVIg) shows limited success for neonatal sepsis due to immature immune systems in premature infants. Research is needed to understand IVIg

More Related Videos

Mapping Infant Immunity with Minimal Input: Integrative Single-Cell and Multiomic Profiling

Mapping Infant Immunity with Minimal Input: Integrative Single-Cell and Multiomic Profiling

Published on: April 3, 2026

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

Related Experiment Videos

Last Updated: Jun 17, 2026

Intravenous Injections in Neonatal Mice

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

Mapping Infant Immunity with Minimal Input: Integrative Single-Cell and Multiomic Profiling

Mapping Infant Immunity with Minimal Input: Integrative Single-Cell and Multiomic Profiling

Published on: April 3, 2026

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

Area of Science:

Neonatal immunology
Immunotherapy
Premature infant health

Background:

Neonatal sepsis is a significant concern, particularly in very premature infants.
Intravenous immunoglobulin (IVIg) has been explored as a treatment for neonatal sepsis.
Clinical success of IVIg has been modest, possibly due to immature neonatal immune systems.

Purpose of the Study:

To review evidence on IVIg effects on immune function in very premature neonates (<30 weeks gestational age).
To understand how IVIg impacts the developing immune system in this vulnerable population.
To identify future research directions for optimizing IVIg therapy in very premature infants.

Main Methods:

Literature review of studies investigating IVIg in very premature neonates.
Analysis of immune function markers following IVIg administration.
Synthesis of existing data on IVIg's immunoenhancing potential.

Main Results:

Evidence suggests IVIg can modulate immune responses in very premature neonates.
Specific effects of IVIg on immature immune cells require further detailed investigation.
The biological plausibility for IVIg's benefit is high, but clinical outcomes need improvement.

Conclusions:

Understanding IVIg's impact on immature immune systems is crucial for very premature neonates.
Targeted research is necessary to enhance IVIg efficacy in preventing or treating neonatal sepsis.
Optimizing IVIg therapy could improve outcomes for the most vulnerable infants.